The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 Cells

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive disease harboring significant morbidity and mortality despite recent advances in therapy. Regardless of disease severity acute exacerbations (IPF-AEs) may occur leading to considerable loss of function and are the leading cause of dea...

Full description

Bibliographic Details
Main Authors: Benedikt Jäger, Benjamin Seeliger, Oliver Terwolbeck, Gregor Warnecke, Tobias Welte, Meike Müller, Christian Bode, Antje Prasse
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.642855/full
_version_ 1818931491845963776
author Benedikt Jäger
Benedikt Jäger
Benedikt Jäger
Benjamin Seeliger
Oliver Terwolbeck
Gregor Warnecke
Tobias Welte
Meike Müller
Christian Bode
Antje Prasse
Antje Prasse
Antje Prasse
author_facet Benedikt Jäger
Benedikt Jäger
Benedikt Jäger
Benjamin Seeliger
Oliver Terwolbeck
Gregor Warnecke
Tobias Welte
Meike Müller
Christian Bode
Antje Prasse
Antje Prasse
Antje Prasse
author_sort Benedikt Jäger
collection DOAJ
description Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive disease harboring significant morbidity and mortality despite recent advances in therapy. Regardless of disease severity acute exacerbations (IPF-AEs) may occur leading to considerable loss of function and are the leading cause of death in IPF. Histologic features of IPF-AE are very similar to acute respiratory distress syndrome (ARDS), but the underlying mechanisms are incompletely understood. We investigated the role of the NLRP3 inflammasome in IPF and IPF-AE. Bronchoalveolar lavage (BAL) cells were sampled from patients with IPF (n = 32), IPF-AE (n = 10), ARDS (n = 7) and healthy volunteers (HV, n = 37) and the NLRP3-inflammasome was stimulated in-vitro. We found the NLRP3 inflammasome to be hyper-inducible in IPF compared to HV with increased IL-1ß and pro-IL-1ß levels on ELISA upon stimulation as well as increased caspase-1 activity measured by caspase-1p20 immunoblotting. In IPF-AE, IL-1ß was massively elevated to an extent similar to ARDS. To evaluate potential mechanisms, we co-cultured BAL cells with radiated A549 cells (a model to simulate apoptotic alveolar epithelial cells), which led to increased NLRP3 mRNA expression and increased caspase-1 dependent IL-1ß production. In the presence of a reactive oxygen species (ROS) inhibitor (diphenyleneiodonium) and a cathepsin B inhibitor (E64D), NLRP3 expression was suppressed indicating that induction of NLRP3 activation following efferocytosis of apoptotic A549 cells is mediated via ROS and cathepsin-B. In summary, we present evidence of involvement of the NLRP3 inflammasome-caspase pathway in the pathogenesis of IPF-AE, similarly to ARDS, which may be mediated by efferocytosis of apoptotic alveolar epithelial cells in IPF.
first_indexed 2024-12-20T04:17:27Z
format Article
id doaj.art-4ed61995440d48c6a4c13b405fb5200e
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-20T04:17:27Z
publishDate 2021-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-4ed61995440d48c6a4c13b405fb5200e2022-12-21T19:53:44ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-04-011210.3389/fimmu.2021.642855642855The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 CellsBenedikt Jäger0Benedikt Jäger1Benedikt Jäger2Benjamin Seeliger3Oliver Terwolbeck4Gregor Warnecke5Tobias Welte6Meike Müller7Christian Bode8Antje Prasse9Antje Prasse10Antje Prasse11Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, GermanyDepartment of Respiratory Medicine, University Medical Center, Freiburg, GermanyFaculty of Biology, Albert Ludwig University, Freiburg, GermanyDepartment of Respiratory Medicine, Hannover Medical School and Biomedical Research in End-stage and Obstructive Lung Disease (BREATH), German Center for Lung Research (DZL), Hannover, GermanyFraunhofer Institute for Toxicology and Experimental Medicine, Hannover, GermanyDepartment of Heart, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, GermanyDepartment of Respiratory Medicine, Hannover Medical School and Biomedical Research in End-stage and Obstructive Lung Disease (BREATH), German Center for Lung Research (DZL), Hannover, GermanyFraunhofer Institute for Toxicology and Experimental Medicine, Hannover, GermanyDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, GermanyFraunhofer Institute for Toxicology and Experimental Medicine, Hannover, GermanyDepartment of Respiratory Medicine, University Medical Center, Freiburg, GermanyDepartment of Respiratory Medicine, Hannover Medical School and Biomedical Research in End-stage and Obstructive Lung Disease (BREATH), German Center for Lung Research (DZL), Hannover, GermanyIdiopathic pulmonary fibrosis (IPF) is a relentlessly progressive disease harboring significant morbidity and mortality despite recent advances in therapy. Regardless of disease severity acute exacerbations (IPF-AEs) may occur leading to considerable loss of function and are the leading cause of death in IPF. Histologic features of IPF-AE are very similar to acute respiratory distress syndrome (ARDS), but the underlying mechanisms are incompletely understood. We investigated the role of the NLRP3 inflammasome in IPF and IPF-AE. Bronchoalveolar lavage (BAL) cells were sampled from patients with IPF (n = 32), IPF-AE (n = 10), ARDS (n = 7) and healthy volunteers (HV, n = 37) and the NLRP3-inflammasome was stimulated in-vitro. We found the NLRP3 inflammasome to be hyper-inducible in IPF compared to HV with increased IL-1ß and pro-IL-1ß levels on ELISA upon stimulation as well as increased caspase-1 activity measured by caspase-1p20 immunoblotting. In IPF-AE, IL-1ß was massively elevated to an extent similar to ARDS. To evaluate potential mechanisms, we co-cultured BAL cells with radiated A549 cells (a model to simulate apoptotic alveolar epithelial cells), which led to increased NLRP3 mRNA expression and increased caspase-1 dependent IL-1ß production. In the presence of a reactive oxygen species (ROS) inhibitor (diphenyleneiodonium) and a cathepsin B inhibitor (E64D), NLRP3 expression was suppressed indicating that induction of NLRP3 activation following efferocytosis of apoptotic A549 cells is mediated via ROS and cathepsin-B. In summary, we present evidence of involvement of the NLRP3 inflammasome-caspase pathway in the pathogenesis of IPF-AE, similarly to ARDS, which may be mediated by efferocytosis of apoptotic alveolar epithelial cells in IPF.https://www.frontiersin.org/articles/10.3389/fimmu.2021.642855/fullidiopathic pulmonary fibrosisinflammasomeNLRP3acute exacerbationinflammation
spellingShingle Benedikt Jäger
Benedikt Jäger
Benedikt Jäger
Benjamin Seeliger
Oliver Terwolbeck
Gregor Warnecke
Tobias Welte
Meike Müller
Christian Bode
Antje Prasse
Antje Prasse
Antje Prasse
The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 Cells
Frontiers in Immunology
idiopathic pulmonary fibrosis
inflammasome
NLRP3
acute exacerbation
inflammation
title The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 Cells
title_full The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 Cells
title_fullStr The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 Cells
title_full_unstemmed The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 Cells
title_short The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 Cells
title_sort nlrp3 inflammasome caspase 1 pathway is upregulated in idiopathic pulmonary fibrosis and acute exacerbations and is inducible by apoptotic a549 cells
topic idiopathic pulmonary fibrosis
inflammasome
NLRP3
acute exacerbation
inflammation
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.642855/full
work_keys_str_mv AT benediktjager thenlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT benediktjager thenlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT benediktjager thenlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT benjaminseeliger thenlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT oliverterwolbeck thenlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT gregorwarnecke thenlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT tobiaswelte thenlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT meikemuller thenlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT christianbode thenlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT antjeprasse thenlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT antjeprasse thenlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT antjeprasse thenlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT benediktjager nlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT benediktjager nlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT benediktjager nlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT benjaminseeliger nlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT oliverterwolbeck nlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT gregorwarnecke nlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT tobiaswelte nlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT meikemuller nlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT christianbode nlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT antjeprasse nlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT antjeprasse nlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells
AT antjeprasse nlrp3inflammasomecaspase1pathwayisupregulatedinidiopathicpulmonaryfibrosisandacuteexacerbationsandisinduciblebyapoptotica549cells